Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 2,677 Cr.
- Current Price ₹ 829
- High / Low ₹ 888 / 528
- Stock P/E 43.5
- Book Value ₹ 252
- Dividend Yield 0.30 %
- ROCE 10.1 %
- ROE 7.52 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 3.28 times its book value
- Promoter holding is low: 27.2%
- Company has a low return on equity of 10.5% over last 3 years.
- Dividend payout has been low at 12.8% of profits over last 3 years
- Debtor days have increased from 72.1 to 110 days.
- Promoter holding has decreased over last 3 years: -39.0%
- Working capital days have increased from 46.3 days to 131 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
36 | 57 | 108 | 147 | 258 | 396 | 455 | 464 | 590 | 621 | |
35 | 42 | 169 | 87 | 373 | 302 | 320 | 340 | 444 | 469 | |
Operating Profit | 0 | 15 | -62 | 60 | -114 | 94 | 135 | 124 | 146 | 152 |
OPM % | 1% | 26% | -57% | 41% | -44% | 24% | 30% | 27% | 25% | 25% |
3 | 4 | 3 | 2 | 13 | 265 | 15 | 19 | 17 | 20 | |
Interest | 6 | 6 | 8 | 16 | 25 | 26 | 18 | 8 | 16 | 20 |
Depreciation | 5 | 10 | 18 | 26 | 32 | 37 | 41 | 54 | 75 | 76 |
Profit before tax | -7 | 2 | -84 | 21 | -158 | 295 | 90 | 82 | 72 | 77 |
Tax % | 6% | 8% | -29% | 40% | -29% | 37% | 21% | 23% | 19% | |
-8 | 2 | -60 | 12 | -112 | 185 | 71 | 64 | 59 | 62 | |
EPS in Rs | -15.05 | 4.01 | -116.54 | 24.15 | -216.83 | 284.73 | 22.52 | 20.23 | 18.14 | 19.14 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 14% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 32% |
3 Years: | 14% |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 36% |
3 Years: | -32% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
1 Year: | 22% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 11% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 6 | 16 | 16 | 16 | |
Reserves | 4 | 6 | 43 | -217 | -17 | 671 | 727 | 799 | |
131 | 102 | 330 | 246 | 474 | 41 | 32 | 160 | ||
24 | 63 | 115 | 596 | 146 | 149 | 134 | 197 | ||
Total Liabilities | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 | |
59 | 116 | 223 | 275 | 309 | 386 | 471 | 647 | ||
CWIP | 20 | 6 | 42 | 9 | 4 | 28 | 25 | 10 | |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
85 | 53 | 228 | 345 | 297 | 463 | 413 | 514 | ||
Total Assets | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
59 | 61 | 38 | 119 | 129 | 75 | 24 | |||
-53 | -201 | -77 | -67 | -241 | -109 | -129 | |||
-37 | 145 | 6 | 20 | 176 | -33 | 84 | |||
Net Cash Flow | -31 | 4 | -33 | 71 | 64 | -66 | -20 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 91 | 140 | 87 | 69 | 48 | 59 | 110 | |
Inventory Days | 21 | 24 | 89 | ||||||
Days Payable | 76 | 99 | 878 | ||||||
Cash Conversion Cycle | 32 | 15 | -650 | 87 | 69 | 48 | 59 | 110 | |
Working Capital Days | 57 | -43 | -100 | -3 | -23 | -14 | 22 | 131 | |
ROCE % | 7% | -65% | 129% | 18% | 12% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
2d - Krsnaa Diagnostics awarded contract for Radiology Center services.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
2d - Award of Letter of Intent for Radiology Services.
- Closure of Trading Window 2d
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - Krsnaa Diagnostics acquires stake in Apulki Healthcare.
-
Intimation Under Regulation 30 Read With Schedule Lll Of The SEBI (LODR) Regulations, 2015 For Acquisition Of 23.53% Of Stake In Equity Shares Of Apulki Healthcare Private Limited.
25 Sep - Krsnaa Diagnostics to acquire 23.53% stake in Apulki Healthcare.
Annual reports
Concalls
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Service Offerings
The company is one of India’s fastest‑growing, differentiated diagnostics service providers. Its technology-enabled diagnostic services include imaging (including radiology), pathology/clinical laboratory, and tele‑radiology services. It has proven capabilities and the largest presence in the PPP diagnostics segment and extends its services to private and public hospitals, medical colleges, and community health centers in Pan‑India. [1]